Skip to content
Research Article Open access CC BY 4.0

Drug Permeation across the Blood-Brain Barrier: Applications of Nanotechnology

Marc Fakhoury, Ryusuke Takechi, Hani Al-Salami

Journal of Advances in Medicine and Medical Research · pp. 547–556 · Published 31 Dec 2014

10.9734/BJMMR/2015/15493

Abstract

The blood-brain barrier (BBB) is a neurobiological frontier that isolates brain tissues from the blood vascular system. Its main role is to protect the brain and the central nervous system from external fluctuations in hormones, nutrients and drugs, while allowing the passage of water and small lipophilic molecules. Diffusion across the BBB can occur through several biological mechanisms, but the most common one is simple diffusion, which mainly depends on the size, lipid solubility and concentration gradient of the molecule. Because of the highly dense network of capillary endothelium cells found in the BBB, most of the drugs are not able to cross this physiological barrier. Delivering therapeutic agents to the brain is thus a big challenge, which may prevent treatment of important neurological diseases. In order to overcome this difficulty, researchers have used nanotechnology to help the passage of drugs across the BBB. Nanotechnology has significantly contributed to the field of biotechnology by improving the strategies for drug delivery, and by providing novel carriers for safe and effective brain targeting. The aim of this review is to discuss in more details the anatomical structure and the functions of the BBB, as well as its significance in neurological diseases. A closer look will be given at the transport mechanisms across the BBB. This review finally explores the most recent advances in the field of nanotechnology for drug delivery in the brain, and gives meaningful examples of delivery systems developed including the micelles, liposomes, dendrimers, microcapsules and polymeric nanoparticles.

Blood-brain barrier drug delivery nanotechnology neurological disease

References (81)

  1. 1 Biodegradable polymeric nanoparticles based drug delivery systems [DOI]
  2. 2 The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders [DOI]
  3. 3 Drug Transport across the Blood–Brain Barrier [DOI]
  4. 4 New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now? [DOI]
  5. 5 Tight junctions of the blood-brain barrier: development, composition and regulation. [DOI]
  6. 6 Modern methods for delivery of drugs across the blood–brain barrier [DOI]
  7. 7 α-Catenin Is a Molecular Switch that Binds E-Cadherin-β-Catenin and Regulates Actin-Filament Assembly [DOI]
  8. 8 Central nervous system pericytes in health and disease [DOI]
  9. 9 Wnt/β-catenin signaling controls development of the blood–brain barrier [DOI]
  10. 10 Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells [DOI]
  11. 11 The blood-brain barrier in brain homeostasis and neurological diseases [DOI]
  12. 12 Occludin is a functional component of the tight junction [DOI]
  13. 13 More than just water channels: unexpected cellular roles of aquaporins [DOI]
  14. 14 Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches [DOI]
  15. 15 Nanoparticles for Brain Drug Delivery [DOI]
  16. 16 Strategies to advance translational research into brain barriers [DOI]
  17. 17 Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood–Brain Tumor Barrier [DOI]
  18. 18 Nanocarriers: Promising Vehicle for Bioactive Drugs [DOI]
  19. 19 The p120 catenin family: Complex roles in adhesion, signaling and cancer [DOI]
  20. 20 Blood-brain barrier transcytosis of insulin in developing rabbits [DOI]
  21. 21 Blood-Brain Barrier Carrier-Mediated Transport and Brain Metabolism of Amino Acids [DOI]
  22. 22 Pathways for Small Molecule Delivery to the Central Nervous System across the Blood-Brain Barrier [DOI]
  23. 23 Review: Role of developmental inflammation and blood–brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases [DOI]
  24. 24 Structure of the Dimerization and β-Catenin- Binding Region of α-Catenin [DOI]
  25. 25 Physiology and pharmacological role of the blood-brain barrier.
  26. 26 The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals [DOI]
  27. 27 Claudin Family of Proteins and Cancer: An Overview [DOI]
  28. 28 Poly(amidoamine) dendrimer–drug conjugates with disulfide linkages for intracellular drug delivery [DOI]
  29. 29 Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain [DOI]
  30. 30 Defective E-cadherin/catenin complexes in human cancer [DOI]
  31. 31 Carrier-mediated or specialized transport of drugs across the blood–brain barrier [DOI]
  32. 32 Adherens junctions and β-catenin-mediated cell signalling in a non-metazoan organism [DOI]
  33. 33 Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis [DOI]
  34. 34 Gum Arabic coated magnetic nanoparticles with affinity ligands specific for antibodies [DOI]
  35. 35 Wheat-Gluten-Based Natural Polymer Nanoparticle Composites [DOI]
  36. 36 Drug Delivery to The Brain Using Polymeric Nanoparticles: A Review [DOI]
  37. 37 Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier [DOI]
  38. 38 Brain-Targeted Delivery of Trans-Activating Transcriptor-Conjugated Magnetic PLGA/Lipid Nanoparticles [DOI]
  39. 39 Protection of the Blood-Brain Barrier by Pentosan Against Amyloid-β-Induced Toxicity [DOI]
  40. 40 Development of Dehydration-Rehydration Liposomal System Using Film Hydration Technique Followed by Sonication [DOI]
  41. 41 Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain [DOI]
  42. 42 Analysis of Biotinylated Generation 4 Poly(amidoamine) (PAMAM) Dendrimer Distribution in the Rat Brain and Toxicity in a Cellular Model of the Blood-Brain Barrier [DOI]
  43. 43 Endothelial cell motility is compatible with junctional integrity [DOI]
  44. 44 A Polyphenylene Dendrimer Drug Transporter with Precisely Positioned Amphiphilic Surface Patches [DOI]
  45. 45 Aquaporin‐1 in the peritoneal membrane: implications for peritoneal dialysis and endothelial cell function [DOI]
  46. 46 Image-guided drug delivery to the brain using nanotechnology [DOI]
  47. 47 Carrier‐mediated transport systems for glucose in mucosal cells of the human oral cavity [DOI]
  48. 48 In Vitro Models to Study the Blood Brain Barrier [DOI]
  49. 49 PAMAM-drug complex for delivering anticancer drug across blood-brain barrier in-vitro and in-vivo [DOI]
  50. 50 Preparation and In Vitro Analysis of Microcapsule Thalidomide Formulation for Targeted Suppression of TNF-α [DOI]
  51. 51 Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton [DOI]
  52. 52 Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis [DOI]
  53. 53 Polymeric micelles – a new generation of colloidal drug carriers [DOI]
  54. 54 Astrocyte–endothelial interactions and blood–brain barrier permeability* [DOI]
  55. 55 Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier [DOI]
  56. 56 Human junction adhesion molecule regulates tight junction resealing in epithelia [DOI]
  57. 57 Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery [DOI]
  58. 58 Junctional adhesion molecules (JAMs): more molecules with dual functions? [DOI]
  59. 59 Structure of the Blood–Brain Barrier and Its Role in the Transport of Amino Acids [DOI]
  60. 60 Drug delivery to the central nervous system: A review
  61. 61 Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells [DOI]
  62. 62 Dendrimer-Encapsulated Camptothecins: Increased Solubility, Cellular Uptake, and Cellular Retention Affords Enhanced Anticancer Activity In vitro [DOI]
  63. 63 Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation [DOI]
  64. 64 ATP is required for receptor-mediated endocytosis in intact cells. [DOI]
  65. 65 Quantum Dots Targeted to the Assigned Organelle in Living Cells [DOI]
  66. 66 Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat [DOI]
  67. 67 Polymeric micelles anchored with TAT for delivery of antibiotics across the blood–brain barrier [DOI]
  68. 68 Liposomes for brain delivery [DOI]
  69. 69 OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma [DOI]
  70. 70 Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. [DOI]
  71. 71 Nanobiotechnology-based Drug Delivery in Brain Targeting [DOI]
  72. 72 Dendrimers as Novel Systems for Delivery of Neuropharmaceuticals to the Brain [DOI]
  73. 73 Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
  74. 74 Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study [DOI]
  75. 75 Dendrimers As Vectors for Genetic Material Delivery to the Nervous System [DOI]
  76. 76 Development of high drug-loading nanomicelles targeting steroids to the brain [DOI]
  77. 77 Use of Artificial Cell Microcapsule Containing Thalidomide for Treating TNBS-induced Crohn's Disease in Mice [DOI]
  78. 78 Brain Delivery Systems via Mechanism Independent of Receptor-Mediated Endocytosis and Adsorptive-Mediated Endocytosis [DOI]
  79. 79 Artificial Cells in Immobilization Biotechnology [DOI]
  80. 80 CRYSTAL STRUCTURE OF THE ALPHA-CATENIN DIMERIZATION DOMAIN [DOI]
  81. 81 Editorial: [Hot Topic HIV and Substance Abuse] [DOI]

Cited by 52

Alzheimer’s disease: review of current nanotechnological therapeutic strategies

Ewa Baranowska-Wójcik, Dominik Szwajgier · Expert Review of Neurotherapeutics · 2020

Engineering and Unlocking the Potential of Photoluminescent Carbogenic Nanomaterials in Antiviral and Anticancer Therapeutic Delivery, and Regenerative Medicine

Bommanahalli Nagaraju Kumara, Palraj Kalimuthu, Kariate Sudhakara Prasad · ACS Applied Bio Materials · 2025

Nanoparticle-based drug delivery across the blood-brain barrier for treating malignant brain glioma

Vishwanath Kurawattimath, Barnabas Wilson, Kannoth Mukundan Geetha · OpenNano · 2023

Nanotechnology for Biomedical Devices: Cancer Treatment

Andrew Cappuccitti, Benjamin Daniels, Christina Galloro · Materials Horizons: From Nature to Nanomaterials · 2022

Blood-Brain Delivery Methods Using Nanotechnology

Daniel Mihai Teleanu, Cristina Chircov, Alexandru Mihai Grumezescu · Pharmaceutics · 2018

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease

Nazeer Hussain Khan, Maria Mir, Ebenezeri Erasto Ngowi · Frontiers in Bioengineering and Biotechnology · 2021

Showing 20 of 52 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

47

Page views

0

PDF downloads

6

Outbound clicks

52

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.